Literature DB >> 25218897

Oroxylin A enhances memory consolidation through the brain-derived neurotrophic factor in mice.

Dong Hyun Kim1, Younghwan Lee2, Hyung Eun Lee2, Se Jin Park2, Su Jin Jeon3, Se Jin Jeon2, Jae Hoon Cheong4, Chan Young Shin5, Kun Ho Son6, Jong Hoon Ryu7.   

Abstract

Memory consolidation is a process by which acquired information is transformed from a labile into a more stable state that can be retrieved at a later time. In the present study, we investigated the role of oroxylin A on the memory consolidation process in mice. Oroxylin A improved the memory retention administered at 0 h, 1 h and 3 h after training in a passive avoidance task, suggesting that oroxylin A facilitates memory consolidation. Oroxylin A increased mature brain-derived neurotrophic factor (mBDNF) levels in the hippocampus from 6h to 24h after administration. Moreover, 3h post-training administration of oroxylin A enhanced the mBDNF level at 9h after the acquisition trial compared to the level at 6h after the acquisition trial. However, 6h post-training administration of oroxylin A did not increase the mBDNF level at 9h after the acquisition trial. Blocking mBDNF signaling with recombinant tropomyosin receptor kinase B (TrkB)-Fc or k252a at 9h after the acquisition trial obstructed the effect of oroxylin A on memory consolidation. Taken together, our data suggest that oroxylin A facilitates memory consolidation through BDNF-TrkB signaling and confirms that the increase of BDNF in a specific time window plays a crucial role in memory consolidation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDNF; Memory consolidation; Oroxylin A; Passive avoidance test

Mesh:

Substances:

Year:  2014        PMID: 25218897     DOI: 10.1016/j.brainresbull.2014.09.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  The effect of maslinic acid on cognitive dysfunction induced by cholinergic blockade in mice.

Authors:  Ho Jung Bae; Jihyun Kim; Jaehoon Kim; Nayeon Goo; Mudan Cai; Kyungnam Cho; Seo Yun Jung; Huiyoung Kwon; Dong Hyun Kim; Dae Sik Jang; Jong Hoon Ryu
Journal:  Br J Pharmacol       Date:  2020-04-01       Impact factor: 8.739

2.  Antidepressant-like activity of oroxylin A in mice models of depression: A behavioral and neurobiological characterization.

Authors:  Zhong-Hua Wu; Hua Fan; Shang-Yan Gao; Yan-Fei Jin; Bo Jiang; Jian Shen
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988

Review 3.  Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.

Authors:  Hardeep Singh Tuli; Vivek Kumar Garg; Ajay Kumar; Diwakar Aggarwal; Uttpal Anand; Nidarshana Chaturvedi Parashar; Adesh K Saini; Ranjan K Mohapatra; Kuldeep Dhama; Manoj Kumar; Tejveer Singh; Jagjit Kaur; Katrin Sak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-10       Impact factor: 3.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.